---
figid: PMC9414242__pharmaceutics-14-01581-g002
pmcid: PMC9414242
image_filename: pharmaceutics-14-01581-g002.jpg
figure_link: /pmc/articles/PMC9414242/figure/pharmaceutics-14-01581-f002/
number: Figure 2
figure_title: ''
caption: A scheme to illustrate the rationale strategies combining PD-1/PD-L1 blockers
  with other therapies using nanoplatforms. PDT, photodynamic therapy; PTT, photothermal
  therapy; NPs, nanoparticles.
article_title: Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1
  Pathway for Cancer Treatment.
citation: Xin Yu, et al. Pharmaceutics. 2022 Aug;14(8):1581.
year: '2022'

doi: 10.3390/pharmaceutics14081581
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- PD-1/PD-L1
- immune checkpoint
- nanoparticles
- delivery nanoplatforms
- cancer immunotherapy

---
